Tavexia Lifecare Limited vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Sattva Sukun Lifecare Ltd is ₹ 1.15 as of 23 Oct 15:30 . The P/E Ratio of Sattva Sukun Lifecare Ltd changed from 367.7 on March 2022 to 73 on March 2026 . This represents a CAGR of -27.63% over 5 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 0 on March 2022 to 0 on March 2026 . This represents a CAGR of 0.0% over 5 years The Market Cap of Sattva Sukun Lifecare Ltd changed from ₹ 7.06 crore on March 2022 to ₹ 28 crore on March 2026 . This represents a CAGR of 31.73% over 5 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 5 years The revenue of Sattva Sukun Lifecare Ltd for the Jun '26 is ₹ 0.76 crore as compare to the Mar '26 revenue of ₹ 14.35 crore. This represent the decline of -94.7% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Sattva Sukun Lifecare Ltd for the Jun '26 is ₹ -0.12 crore as compare to the Mar '26 ebitda of ₹ -0.68 crore. This represent the decline of -82.35% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Sattva Sukun Lifecare Ltd changed from ₹ 0.34 crore to ₹ -0.16 crore over 9 quarters. This represents a CAGR of NaN% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Sattva Sukun Lifecare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Sattva Sukun Lifecare Ltd

Mayukh Dealtrade Limited (formerly known as Mayukh Commercial Ltd) was incorporated in August, 1980.
The Company name was changed from Mayukh Commercial Limited to Mayukh Dealtrade Limited on November 05, 2015. Earlier, the Company was registered as a Non Banking Financial Company engaged into trading / dealing in shares as main business.
It invests in equities through the secondary markets and provide Loans & Advances to Corporates, Individuals, etc.
The Company is presently into trading in sarees having a wide variety of fabrics and designs during the year 2014-15.
The main object of the Company is to cater to the growing industry and offer its products to all the age groups.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Sattva Sukun Lifecare Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, TAVEXIA LIFECARE LIMITED or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of TAVEXIA LIFECARE LIMITED is 44 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of TAVEXIA LIFECARE LIMITED and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of TAVEXIA LIFECARE LIMITED and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for TAVEXIA LIFECARE LIMITED and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the TAVEXIA LIFECARE LIMITED stock price is INR ₹1.15. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of TAVEXIA LIFECARE LIMITED and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of TAVEXIA LIFECARE LIMITED and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.